Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
CONy 2023
ACTRIMS 2023
ISC 2023
EHC 2022
AES 2022
WSC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
thrombolysis
3:55
Current clinical practices and opinions of intra-arterial thrombolysis
Adnan Qureshi
• 13 Mar 2023
4:20
Adjunctive intra-arterial thrombolysis in patients with basilar artery occlusion
Adnan Qureshi
• 13 Mar 2023
4:50
Skipping thrombolysis in acute stroke with tandem occlusion
Thanh Nguyen
• 15 Feb 2023
5:04
Tenecteplase versus alteplase in a real-world setting
Adnan Qureshi
• 13 Mar 2023
4:46
ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke
Thanh Nguyen
• 15 Feb 2023
3:43
Key data at ISC 2023: DAPT vs IVT, alteplase vs tenecteplase, and EVT in large core stroke
Thanh Nguyen
• 15 Feb 2023
2:21
Reperfusion therapy and post-stroke epilepsy risk
Carolina Ferreira-Atuesta
• 15 Dec 2022
3:01
Outcome prediction after stroke treatment
Urs Fischer
et al.
• 27 Oct 2022
3:24
The challenges of non-inferiority trials in stroke
Urs Fischer
et al.
• 27 Oct 2022
1:31
Thrombectomy alone versus with prior tenecteplase: what do we know?
Urs Fischer
et al.
• 27 Oct 2022
1:07
Could tenecteplase replace alteplase as a treatment for acute ischemic stroke?
Nishita Singh
• 25 Oct 2022
5:16
Individual patient data meta-analysis of direct thrombectomy versus bridging thrombolysis
Urs Fischer
et al.
• 27 Oct 2022
6:29
Mechanical thrombectomy with or without thrombolysis: reviewing the evidence
Adnan Qureshi
• 20 Oct 2022
2:23
Phase II Endovascular Stroke Treatment Only (ESTO) Trial
Adnan Qureshi
• 20 Oct 2022
6:25
Tenecteplase versus alteplase: impact of time to thrombolysis on clinical outcomes
Nishita Singh
• 25 Oct 2022
8:00
Unresolved questions on post-stroke anticoagulation in atrial fibrillation
Nils Peters
et al.
• 4 May 2022
1
2
3
4
Next